Stay updated with breaking news from Ming Yan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) shares dropped 3.7% during mid-day trading on Monday . The stock traded as low as $11.44 and last traded at $11.48. Approximately 23,005 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 999,321 shares. The stock had previously closed at $11.92. […]
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 6,510,000 shares, an increase of 15.2% from the March 31st total of 5,650,000 shares. Approximately 6.0% of the shares of the company are short […]
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating)’s share price fell 5.1% during trading on Monday . The company traded as low as $8.69 and last traded at $8.72. 463,365 shares traded hands during mid-day trading, a decline of 34% from the average session volume of 700,289 shares. The stock had previously closed at $9.19. Analysts […]
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CTO Ming Yan sold 20,000 shares of the stock in a transaction on Monday, March 20th. The shares were sold at an average price of $9.29, for a total value of $185,800.00. Following the completion of the sale, the chief technology officer now owns 7,906,053 shares of the […]
California has seen more people die from the recent storms than it did in last year's wildfires.